AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

The 2020 update of the Canadian Stroke Best Practice Recommendations (CSBPR) for the
Secondary Prevention of Stroke includes current evidence-based recommendations and …

Background Guidelines recommend a trial of one or more antiarrhythmic drugs before
catheter ablation is considered in patients with atrial fibrillation. However, first-line ablation …

Background Atrial fibrillation is a chronic, progressive disorder, and persistent forms of atrial
fibrillation are associated with increased risks of thromboembolism and heart failure …

Patients with widespread atherosclerosis such as peripheral artery disease (PAD) have a
high risk of cardiovascular and limb symptoms and complications, which affects their quality …

Sleep-disordered breathing (SDB), characterized by specific underlying physiological
mechanisms, comprises obstructive and central pathophysiology, affects nearly 1 billion …

The 2022 update of the Canadian Stroke Best Practice Recommendations (CSBPR) for
Acute Stroke Management, 7th edition, is a comprehensive summary of current evidence …

Atrial fibrillation (AF), the most common sustained arrhythmia observed in clinical practice, is
a chronic and progressive disorder characterized by exacerbations and remissions …

Given its complexity, the management of atrial fibrillation (AF) has relied increasingly on
expert guideline recommendations; however, discrepancies between these professional …

The technological evolution and widespread availability of wearables and handheld ECG
devices capable of screening for atrial fibrillation (AF), and their promotion directly to …